Navigation Links
Precision Therapeutics Named on Inc. 500|5000 2011 List and Recognized for Achievements in Personalized Medicine Industry
Date:8/23/2011

PITTSBURGH, Aug. 23, 2011 /PRNewswire/ -- Inc. Magazine has ranked Precision Therapeutics 293rd on its prestigious list of the 500 fastest growing privately owned companies in the U.S. with a three year annual compound growth rate of 79 percent. This award recognizes the significant accomplishments of the fastest-growing privately held entrepreneurial companies in America, whose performances have established them among the best in their industries.  Precision was recognized as one of the top 31 companies in the healthcare industry.

There are nearly 7 million private, employee-based firms in America, and only the very best are awarded the distinction of being named to the Inc 500|5000, the gold standard of entrepreneurial success according to Inc.com. Precision Therapeutics and the other Inc. 500 Honorees are responsible for collectively generating more than 36,000 jobs over the past three years, making the list perhaps the best example of the impact private, fast-growing companies can have on the economy.  

"We are very excited to be ranked as one of the top 30 companies in the health category of the Inc. 500," said Sean McDonald, CEO of Precision. "The work we do to support physicians and patients in the treatment of cancer is important and rewarding. This list reflects not only the success of Precision Therapeutics employees but the commitment Pittsburgh has made to supporting healthcare and the life-science industry."

The 2011 Inc. 500|5000 will be available online at Inc.com on August 24, 2011, and the magazine's September issue will hit the newsstands around that time. For more information, please visit www.inc.com/5000.

Precision Therapeutics commitment to cancer care was further recognized by several other regional and national organizations for significant achievements in the life-science industry. Precision has recently been recognized by The Pittsburgh Business Times as one of the Top 100 fastest-growing companies in the region, and received the 2011 Smart Business Pacesetter Award, which commemorates the business leaders in the Greater Pittsburgh area who are setting the pace for the region with revenue growth and overall success.  Precision has further been honored with the Pittsburgh Technology Council Tech 50 Award for continued innovation in personalized medicine.

"Being recognized by these prestigious institutions for our regional growth, innovation and influence on the people who live in this region is such an honor for me and my team as we work toward our goal of optimizing each patient's quality of life and chance for survival by designing superior technology that offers hope for greater control of cancer," said McDonald.

About Precision Therapeutics

Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer care. Precision offers a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the cancer care continuum.

Precision's state of the art Comprehensive Tumor Profiling is an integrated straightforward approach combining three core platforms of personalized medicine to capture the total sum of genomic, proteomic and functional information for each patient's cancer through a portfolio of multi-platform tests for cancer treatment in multiple tumor types.

Precision's first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual's malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician. Precision currently receives ChemoFx® specimens from 271 top medical institutions including 20 of the 21 National Comprehensive Cancer Network (NCCN) Member Institutions, and 8 of the US News and World Report Top 10 Hospitals for Cancer Care. To date, ChemoFx® Patient Reports have been provided for over 60,000 patient specimens, using 105 unique chemotherapy treatments and combinations.

For more information, visit www.precisiontherapeutics.com or www.chemofx.com


'/>"/>
SOURCE Precision Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers
2. Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients
3. TechPrecision Corporation Receives $1.6 Million in New Orders from Existing Customers
4. Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR
5. Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer
6. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
7. Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
8. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
9. Applied Precision Exhibit at the Biophysical Society Annual Meeting Showcases New Microscopy Solutions for Life Science Industries
10. TechPrecision Corporation Receives New $450,000 Medical Purchase Order
11. Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Jan 17, 2017 Research and Markets has ... Industry 2016-2020" report to their offering. ... The global fluoropolymer market in the ... period 2016-2020. Global Fluoropolymer Market in the Healthcare ... with inputs from industry experts. The report covers the market landscape ...
(Date:1/17/2017)... 2017  In a letter to President-elect Donald ... outlines AARP,s priorities for Americans age 50 and ... to affordable health care coverage, and lowering the cost ... writes to President-elect Trump that "Our nearly 38 million ... you to protect their Medicare and Social Security benefits, ...
(Date:1/17/2017)... DIEGO , Jan. 17, 2017  In a preview ... th Annual Congress, Astute Medical, Inc., developer of the ... of the test, which identifies hospital patients at risk of ... will take place this month at the Hawaii ... from January 21 through January 25. AKI is ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading audit, tax, ... in its IT Advisory Services practice . Rossi is the third technology consulting ... for strategic IT guidance grows, and the practice continues to expand.     , Bringing more ...
(Date:1/17/2017)... ... 17, 2017 , ... The Sharie Withers Agency, a full-service ... latest beneficiary of their thriving community involvement program. The current campaign fundraises to ... dreams of terminally ill patients. Donations to this worthy cause may now be ...
(Date:1/17/2017)... ... January 17, 2017 , ... Twelve (12) years ago the ... Education program forged a relationship built upon the foundation of sports safety. ... of both student members and certified members of the Athletic Trainers’ Society of ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... Gym Source, ... of a new showroom in East Hanover, New Jersey. , “We are elated to ... “The new innovative in-store concept is designed to give clients a seamless and motivating ...
(Date:1/16/2017)... ... 16, 2017 , ... Houston dentist, Dr. Behzad Nazari, announces ... consultations and financing for orthodontics for a limited time. Complimentary for a limited ... their orthodontic options. Walk-in, late-evening, Saturday, and same-day appointments are available. Antoine Dental ...
Breaking Medicine News(10 mins):